Help:WikiPathways Portals

From WikiPathways

Community Featured Pathways IEM Degradation pathway of sphingolipids, including diseases (Homo sapiens) Degradation pathway of sphingolipids, including diseases

Community Featured Pathways COVID-19 nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell (Homo sapiens) nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell

Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area.

The main advantages of portals include:

• Simplified drawing and collecting your pathways
• Help to keep track of ‘works-in-progress’ with collaborators
• Help attribute credit for pathway authors and curators
• Attract new collaborators
• Help to define a community

Creating a portal is easy using existing templates available from WikiPathways.

If you are interested, please consult the portal maintenance guide and contact us for assistance.

WikiPathways has a growing list of portals:

• Adverse Outcome Pathway
• Inherited Metabolic Disorders (IMDs), or Inborn Errors of Metabolism (IEM)
• California Institute for Regenerative Medicine, CIRM
• COVID-19
• Clinical Proteomic Tumor Analysis Consortium, CPTAC
• Disease
• ExRNA
• Lipids
• Micronutrients
• Nanomaterials
• NetPath
• Plant Pathways
• Rare Disease
• Renal Genomics
• Reactome
• Skeletal Dysplasia
• WormBase